GSK-110021

Study Sponsor: GSK

Study Title

Efficacy of GSK Biologicals’ candidate malaria vaccine (257049) against malaria disease caused by P. falciparum infection in infants and children in Africa

Medicine or Vaccine (generic name)

RTS,S Vaccine

Sponsor Identification Number

110021

Trial Registry Identification Number(#'s)

NCT00866619 2012-005716-26

Medical Condition

Malaria

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=110021

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00866619

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2012-005716-26

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An extension study 200559 was conducted. An annotated case report form is not available for this study. A blank case report form will be provided.

Date Added to this Site

February 2017